Hot Pursuit     23-Sep-24
Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection
Glenmark Pharmaceuticals surged 7.99% after the pharma major announced that its formulation manufacturing facility located in Chhatrapati Sambhaji Nagar, Maharashtra, has successfully cleared the USFDA inspection with zero observations.
The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US Food and Drug Administration (USFDA) has issued Form 483 with zero observations.

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company with presence across specialty, generics and OTC businesses.

The drug maker reported consolidated net profit of Rs 340.27 crore in Q1 FY25, significantly higher from Rs 14.48 crore in Q1 FY24. Revenue from operations increased 6.85% year on year (YoY) to Rs 3,244.19 crore in the quarter ended 30 June 2024.

Previous News
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
 ( Corporate News - 17-Apr-25   20:08 )
  Glenmark Pharma’s US arm set to launch generic Adderall tablets
 ( Hot Pursuit - 17-Apr-25   08:04 )
  Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
 ( Corporate News - 16-Apr-25   19:53 )
  Glenmark Pharmaceuticals Ltd slips for fifth straight session
 ( Hot Pursuit - 11-Apr-25   13:35 )
  Glenmark Pharmaceuticals announces change in senior management
 ( Corporate News - 07-Apr-25   09:00 )
  Glenmark launches Vancomycin Hydrochloride for injection USP in the USA
 ( Hot Pursuit - 01-Apr-25   10:31 )
  Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP
 ( Corporate News - 01-Apr-25   09:40 )
  Nifty trades above 23,250 mark; realty shares climb
 ( Market Commentary - Mid-Session 21-Mar-25   10:36 )
  Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution
 ( Hot Pursuit - 21-Mar-25   09:49 )
  Glenmark Pharmaceuticals launches Empagliflozin in India
 ( Corporate News - 12-Mar-25   13:29 )
  Glenmark Pharma launches generic Empagliflozin in India
 ( Hot Pursuit - 12-Mar-25   11:38 )
Other Stories
  Ramkrishna Forgings drops after discrepancies found in inventory audit
  28-Apr-25   17:52
  TVS Motor gains after Q4 PAT climb 76% YoY to Rs 852 cr
  28-Apr-25   16:36
  UltraTech Cement Q4 PAT rises 10% YoY to Rs 2,482 cr; declares dividend of Rs 77.50/sh
  28-Apr-25   16:13
  IDBI Bank gains after Q4 PAT rises 26% YoY to Rs 2,051cr
  28-Apr-25   15:44
  Shree Digvijay Cement ends lower after weak Q4 performance
  28-Apr-25   15:41
  IRFC slips as Q4 PAT declines 2% YoY to Rs 1,682 cr
  28-Apr-25   15:18
  Zensar Tech gains after Q4 PAT climbs 10% QoQ to Rs 177 cr
  28-Apr-25   15:05
  Kopran jumps as USFDA inspection at subsidiary's plant concludes smoothly
  28-Apr-25   15:03
  Tejas Networks Ltd leads losers in 'A' group
  28-Apr-25   15:00
  GACM Technologies Ltd leads losers in 'B' group
  28-Apr-25   14:45
Back Top